725 related articles for article (PubMed ID: 15830281)
1. Updated treatment approach to hepatocellular carcinoma.
Llovet JM
J Gastroenterol; 2005 Mar; 40(3):225-35. PubMed ID: 15830281
[TBL] [Abstract][Full Text] [Related]
2. Chemoembolization for hepatocellular carcinoma.
Bruix J; Sala M; Llovet JM
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S179-88. PubMed ID: 15508083
[TBL] [Abstract][Full Text] [Related]
3. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of hepatocellular carcinoma: the BCLC staging classification.
Llovet JM; Brú C; Bruix J
Semin Liver Dis; 1999; 19(3):329-38. PubMed ID: 10518312
[TBL] [Abstract][Full Text] [Related]
5. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
6. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.
Wade R; South E; Anwer S; Sharif-Hurst S; Harden M; Fulbright H; Hodgson R; Dias S; Simmonds M; Rowe I; Thornton P; Eastwood A
Health Technol Assess; 2023 Dec; 27(29):1-172. PubMed ID: 38149643
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
[TBL] [Abstract][Full Text] [Related]
8. Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.
Jun CH; Yoon JH; Cho E; Shin SS; Cho SB; Kim HJ; Park CH; Kim HS; Choi SK; Rew JS
Medicine (Baltimore); 2017 Apr; 96(17):e6745. PubMed ID: 28445298
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
10. Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.
Gandhi M; Choo SP; Thng CH; Tan SB; Low AS; Cheow PC; Goh AS; Tay KH; Lo RH; Goh BK; Wong JS; Ng DC; Soo KC; Liew WM; Chow PK;
BMC Cancer; 2016 Nov; 16(1):856. PubMed ID: 27821083
[TBL] [Abstract][Full Text] [Related]
11. Advanced hepatocellular carcinoma: which staging systems best predict prognosis?
Huitzil-Melendez FD; Capanu M; O'Reilly EM; Duffy A; Gansukh B; Saltz LL; Abou-Alfa GK
J Clin Oncol; 2010 Jun; 28(17):2889-95. PubMed ID: 20458042
[TBL] [Abstract][Full Text] [Related]
12. Non-surgical therapies of hepatocellular carcinoma.
Llovet JM; Sala M
Eur J Gastroenterol Hepatol; 2005 May; 17(5):505-13. PubMed ID: 15827440
[TBL] [Abstract][Full Text] [Related]
13. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
Choi JY
Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.
Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ
Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Hepatocellular Carcinoma.
Díaz-González Á; Reig M; Bruix J
Dig Dis; 2016; 34(5):597-602. PubMed ID: 27332893
[TBL] [Abstract][Full Text] [Related]
16. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis.
Salhab M; Canelo R
J Cancer Res Ther; 2011; 7(4):463-75. PubMed ID: 22269411
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hepatocellular carcinoma.
Forner A; Hessheimer AJ; Isabel Real M; Bruix J
Crit Rev Oncol Hematol; 2006 Nov; 60(2):89-98. PubMed ID: 16860993
[TBL] [Abstract][Full Text] [Related]
18. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
[TBL] [Abstract][Full Text] [Related]
19. Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohorts.
Schellhaas B; Strobel D; Stumpf M; Ganslmayer M; Pfeifer L; Goertz RS; Neurath MF; Zopf S
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1422-1427. PubMed ID: 30052538
[TBL] [Abstract][Full Text] [Related]
20. Management of hepatocellular in the United States.
Mokdad AA; Hester CA; Singal AG; Yopp AC
Chin Clin Oncol; 2017 Apr; 6(2):21. PubMed ID: 28482674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
